Developer docs
API playgroundTry for free, no card

Search company profiles

Hilltop BioSciences

Full company profile

uuid0000nos

Namestring
Hilltop BioSciences
Legal namestring
Hilltop BioSciences, Inc.
Websiteurl
hilltopbio.com
Company typeenum
Private
Founded yearint
2018
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMansfield, United States
HQ citystring
Mansfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary biologics, regenerative medicine, equine therapeutics, orthobiologics, canine therapeutics
Industry3 codes
1Equine Therapeutics (Rx)
CodeHLAMAEACPrimaryYes
2Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing)
CodeHLAMANAIPrimaryNo
3Exosome & Extracellular Vesicle (EV) Therapeutics
CodeHLAMANAEPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Veterinary Services541940
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Veterinary Regenerative Biologics
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model1 record
1Veterinary Biologic Product Sales
TypeOne Time License
Description

Hilltop Bio generates revenue through the sale of regenerative biologic products to licensed veterinarians. Products include Regenaflex-RT, Regenaflex-K9, Strydaflex, Strydaflex-K9, Regenaflex-M, Regenaflex-Gel, PureOptic, and Regenaflex-M 25mm discs. Sales occur through a B2B e-commerce platform requiring veterinary registration and through veterinary distribution partners. Products are priced up to $1,300 per unit.

hilltopbio.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Personnel
Pricing details1 tier
1Unit-based product pricing for veterinary regenerative biologics across four therapeutic categories: soft tissue, joint health, wound care, and ophthalmic health.
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products are sold per unit through the online store. 15 products listed with highest price at $1,300.00. No public pricing disclosed; account registration required.

hilltopbio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Hilltop Bio develops and manufactures a portfolio of regenerative biologic products derived from equine birth-derived tissues using its proprietary BioStabyl™ lyophilization process. The products are sold exclusively to licensed veterinarians for the treatment of soft tissue injuries, joint conditions, wound care, and ophthalmic conditions in equine and canine patients. The portfolio spans Regenaflex, Strydaflex, and PureOptic product lines.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Trusted in over 1,000 clinics by general practitioners and board-certified specialists
+3 more records
Product overview1 text field

Hilltop Bio is a veterinary biotechnology company offering a portfolio of seven commercially available regenerative biologic products for equine and canine patients, plus one product in development. The product line spans four therapeutic categories: SOFT TISSUE (Regenaflex-RT and Regenaflex-K9 containing bioscaffold materials), JOINT HEALTH (Strydaflex and Strydaflex-K9 with proteomically characterized factors), WOUND CARE (Regenaflex-M membrane and Regenaflex-Gel topical), and OPHTHALMIC HEALTH (PureOptic). All products are derived from birth-derived tissue using the proprietary BioStabyl™ lyophilization process, are room-temperature stable, and require veterinary authorization. The company also has LPAT in development, an amnion-derived therapy for feline applications.

Product and service7 records
1Regenaflex-RT
CategorySoft Tissue Regenerative Biologic (Equine)
Description

Lyophilized bioscaffold material sourced from birth-derived tissue that supports the ingrowth of reparative tissues for management of soft tissue injuries in equine patients; sold exclusively to licensed veterinarians.

2Regenaflex-K9
CategorySoft Tissue Regenerative Biologic (Canine)
Description

Lyophilized bioscaffold material sourced from birth-derived tissue designed for canine soft tissue applications to support the ingrowth of reparative tissues; sold exclusively to licensed veterinarians.

3Strydaflex
CategoryJoint Health Regenerative Biologic (Equine)
Description

Lyophilized intra-articular joint health product for equine patients with proteomic characterization showing consistent levels of factors that play a beneficial role in the body's normal response to joint damage; sold exclusively to licensed veterinarians.

4Strydaflex-K9
CategoryJoint Health Regenerative Biologic (Canine)
Description

Lyophilized intra-articular joint health product for canine patients with proteomic characterization showing consistent levels of factors that support the body's normal response to joint damage; sold exclusively to licensed veterinarians.

5Regenaflex-M
CategoryWound Care Regenerative Biologic
Description

Sterile lyophilized bioscaffold membrane for wound care applications designed to protect and supplement tissue integration; available in 8 x 10cm, 6 x 6cm, and 25mm disc sizes; sold exclusively to licensed veterinarians.

6Regenaflex-Gel
CategoryWound Care Regenerative Biologic
Description

Lyophilized topical gel bioscaffold for superficial wound care and summer sores where membrane application is not feasible, providing bioscaffold support for tissue healing; sold exclusively to licensed veterinarians.

7PureOptic
CategoryOphthalmic Regenerative Biologic
Description

Lyophilized ophthalmic biologic with optimized viscosity formulation designed to ensure the solution maintains longer-lasting contact with affected ocular tissue (e.g., corneal ulcers); sold exclusively to licensed veterinarians.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-18
Description

Hilltop Bio announced a strategic distribution partnership with Midwest Veterinary Supply in November 2025. The partnership is designed to strengthen and expand access to Hilltop Bio's regenerative therapy products for equine and canine health across the United States veterinary market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Covetrus is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. Covetrus is a major U.S. veterinary distribution company serving practices nationwide.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

MWI is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. MWI is a major U.S. veterinary supply distributor.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Patterson Veterinary is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. Patterson Veterinary is a major U.S. veterinary supply distributor.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Hilltop Bio partners with NOMV, a U.S.-based nonprofit supporting veterinary mental health. The company donates $1 for every unit of product sold to support NOMV's mental health programs. Contributions have exceeded $15,000 over the past two years. The partnership also includes matching donations during AAEP Conference.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Hilltop Bio is a corporate partner of the EQUUS Foundation, the only national U.S. animal welfare organization dedicated to protecting horses. Hilltop Bio has established a $2,500 veterinary scholarship for students at Texas Tech University Veterinary School and donates up to $5,000 in products for the Foundation's Guardian charities through the Lafitte De Muze Matching Gift Campaign.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hilltop BioSciences

Veterinary Regenerative Biologicshilltopbio.com

Hilltop BioSciences firmographics

Firmographics
Name
Hilltop BioSciences
Legal name
Hilltop BioSciences, Inc.
Website
https://hilltopbio.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Hilltop BioSciences industry classification

Industry
Product category
Veterinary Regenerative Biologics
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Veterinary Services (541940)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro primary industry
Equine Therapeutics (Rx) (HLAMAEAC)
akta.pro secondary industries
Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing) (HLAMANAI), Exosome & Extracellular Vesicle (EV) Therapeutics (HLAMANAE)

Keywords

  • Veterinary biologics
  • Regenerative medicine
  • Equine therapeutics
  • Orthobiologics
  • Canine therapeutics

Where Hilltop BioSciences is headquartered

Location

Headquarters

HQ city
Mansfield
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hilltop BioSciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel

Revenue model

  1. Veterinary Biologic Product Sales: Hilltop Bio generates revenue through the sale of regenerative biologic products to licensed veterinarians. Products include Regenaflex-RT, Regenaflex-K9, Strydaflex, Strydaflex-K9, Regenaflex-M, Regenaflex-Gel, PureOptic, and Regenaflex-M 25mm discs. Sales occur through a B2B e-commerce platform requiring veterinary registration and through veterinary distribution partners. Products are priced up to $1,300 per unit.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goUnit-based product pricing for veterinary regenerative biologics across four therapeutic categories: soft tissue, joint health, wound care, and ophthalmic health.

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Hilltop BioSciences product offering

Product offering

Core offering

Hilltop Bio develops and manufactures a portfolio of regenerative biologic products derived from equine birth-derived tissues using its proprietary BioStabyl™ lyophilization process. The products are sold exclusively to licensed veterinarians for the treatment of soft tissue injuries, joint conditions, wound care, and ophthalmic conditions in equine and canine patients. The portfolio spans Regenaflex, Strydaflex, and PureOptic product lines.

Product overview

Hilltop Bio is a veterinary biotechnology company offering a portfolio of seven commercially available regenerative biologic products for equine and canine patients, plus one product in development. The product line spans four therapeutic categories: SOFT TISSUE (Regenaflex-RT and Regenaflex-K9 containing bioscaffold materials), JOINT HEALTH (Strydaflex and Strydaflex-K9 with proteomically characterized factors), WOUND CARE (Regenaflex-M membrane and Regenaflex-Gel topical), and OPHTHALMIC HEALTH (PureOptic). All products are derived from birth-derived tissue using the proprietary BioStabyl™ lyophilization process, are room-temperature stable, and require veterinary authorization. The company also has LPAT in development, an amnion-derived therapy for feline applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Regenaflex-RT Lyophilized bioscaffold material sourced from birth-derived tissue that supports the ingrowth of reparative tissues for management of soft tissue injuries in equine patients; sold exclusively to licensed veterinarians.
  • Regenaflex-K9 Lyophilized bioscaffold material sourced from birth-derived tissue designed for canine soft tissue applications to support the ingrowth of reparative tissues; sold exclusively to licensed veterinarians.
  • Strydaflex Lyophilized intra-articular joint health product for equine patients with proteomic characterization showing consistent levels of factors that play a beneficial role in the body's normal response to joint damage; sold exclusively to licensed veterinarians.
  • Strydaflex-K9 Lyophilized intra-articular joint health product for canine patients with proteomic characterization showing consistent levels of factors that support the body's normal response to joint damage; sold exclusively to licensed veterinarians.
  • Regenaflex-M Sterile lyophilized bioscaffold membrane for wound care applications designed to protect and supplement tissue integration; available in 8 x 10cm, 6 x 6cm, and 25mm disc sizes; sold exclusively to licensed veterinarians.
  • Regenaflex-Gel Lyophilized topical gel bioscaffold for superficial wound care and summer sores where membrane application is not feasible, providing bioscaffold support for tissue healing; sold exclusively to licensed veterinarians.
  • PureOptic Lyophilized ophthalmic biologic with optimized viscosity formulation designed to ensure the solution maintains longer-lasting contact with affected ocular tissue (e.g., corneal ulcers); sold exclusively to licensed veterinarians.

Quantifiable outcome

  • Trusted in over 1,000 clinics by general practitioners and board-certified specialists
  • +3 more outcomes

Companies that use Hilltop BioSciences

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Hilltop BioSciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Hilltop BioSciences partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Midwest Veterinary SupplycoreChannel Partner/ Reseller/ Distributor · 18 November 2025Hilltop Bio announced a strategic distribution partnership with Midwest Veterinary Supply in November 2025. The partnership is designed to strengthen and expand access to Hilltop Bio's regenerative therapy products for equine and canine health across the United States veterinary market.
  • CovetruscoreChannel Partner/ Reseller/ DistributorCovetrus is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. Covetrus is a major U.S. veterinary distribution company serving practices nationwide.
  • MWI (AmerisourceBergen Animal Health)coreChannel Partner/ Reseller/ DistributorMWI is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. MWI is a major U.S. veterinary supply distributor.
  • Patterson VeterinarycoreChannel Partner/ Reseller/ DistributorPatterson Veterinary is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. Patterson Veterinary is a major U.S. veterinary supply distributor.
  • Not One More Vet (NOMV)minorGTM or Marketing PartnerHilltop Bio partners with NOMV, a U.S.-based nonprofit supporting veterinary mental health. The company donates $1 for every unit of product sold to support NOMV's mental health programs. Contributions have exceeded $15,000 over the past two years. The partnership also includes matching donations during AAEP Conference.
  • EQUUS FoundationminorGTM or Marketing PartnerHilltop Bio is a corporate partner of the EQUUS Foundation, the only national U.S. animal welfare organization dedicated to protecting horses. Hilltop Bio has established a $2,500 veterinary scholarship for students at Texas Tech University Veterinary School and donates up to $5,000 in products for the Foundation's Guardian charities through the Lafitte De Muze Matching Gift Campaign.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Hilltop BioSciences competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hilltop BioSciences social profiles

Digital presence

Hilltop BioSciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hilltop BioSciences leadership team

Management profile

Number of profiles

Profiles8 records

Hilltop BioSciences funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hilltop BioSciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hilltop BioSciences

What does Hilltop BioSciences do?

Hilltop Bio develops and manufactures a portfolio of regenerative biologic products derived from equine birth-derived tissues using its proprietary BioStabyl™ lyophilization process. The products are sold exclusively to licensed veterinarians for the treatment of soft tissue injuries, joint conditions, wound care, and ophthalmic conditions in equine and canine patients. The portfolio spans Regenaflex, Strydaflex, and PureOptic product lines.

Is Hilltop BioSciences a public or private company?

Hilltop BioSciences is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hilltop BioSciences founded?

Hilltop BioSciences was founded in 2018. It employs 1 to 10 people.

Where is Hilltop BioSciences based?

Hilltop BioSciences is headquartered in Mansfield, United States, in the North America region.

How does Hilltop BioSciences make money?

One revenue line is on record: veterinary Biologic Product Sales.

Does Hilltop BioSciences have an API?

No public API is recorded for Hilltop BioSciences.

What industry is Hilltop BioSciences in?

Hilltop BioSciences's product category is Veterinary Regenerative Biologics. Its primary akta.pro industry code is HLAMAEAC, Equine Therapeutics (Rx), with a secondary code of HLAMANAI, Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PawprintWhy one-size-fits-all pet care is becoming obsolete: AI changes everythingA newsletter on pet tech trends argues that one-size-fits-all pet care is becoming obsolete as AI enables personalized nutrition, health monitoring, and preventive care solutions. The Farmer's Dog reached $1.2B in annualized revenue with its personalized dog food subscription model, signaling strong consumer demand for tailored pet products. The article also catalogs recent funding rounds for eight pet tech startups, including PetScreening's $80M raise and Hilltop Bio's $5.3M round, as investors pour capital into AI-driven pet care platforms.SecSEC FORM DHilltop Biosciences Inc. filed a Form D with the SEC for an exempt securities offering under Rule 506(b). The company has raised $723,524 of its total offering amount as of March 31, 2023.EIN PresswireMid Atlantic Bio Angels Invests in Veterinary Biotech Company Hilltop BioMid Atlantic Bio Angels (MABA) has invested in veterinary biotech company Hilltop Bio, marking MABA's first engagement with a firm in the veterinary sector. The investment involves individual investors, MABA’s internal Pool III, and its Sidecar Fund II, supporting Hilltop Bio's development of regenerative therapies for inflammatory diseases in animals.SecSEC FORM DHilltop Biosciences Inc. filed a Form D with the SEC to report an exempt securities offering under Rule 506(b). The company has raised $369,919 of its total offering amount as of the filing date in February 2023.SecSEC FORM DHilltop Biosciences Inc. filed a Form D with the Securities and Exchange Commission for an exempt offering of securities under Rule 506(b), initiated on December 20, 2022. The company reported raising $294,920 out of a total offering amount of $1,000,000 from 31 investors as of early January 2023.SecSEC FORM DHilltop Biosciences Inc. filed a Form D with the SEC for an exempt securities offering under Rule 506(b), indicating a total offering amount of $1,430,000 USD. The company has sold $866,345 USD of these securities to 67 investors as of the filing date in October 2021. This regulatory filing discloses the financial parameters and investor count for the private capital raise.SecSEC FORM DHilltop Biosciences Inc. filed a Form D notice with the SEC on August 27, 2021, disclosing an exempt offering of equity pooled investment fund interests under Rule 506(b). The total offering amount was $1,430,000, with $784,320 sold and $645,680 remaining, and 65 investors, including non-accredited investors. No sales commissions or finder's fees were reported.